CardioSignal
Mikko Pänkäälä has a diverse work experience in various industries. In 2016, they became the Chief Scientific Officer at CardioSignal by Precordior, a company focused on developing a mobile application-based technology to improve the detection of heart diseases. Mikko played a key role in the development of the company's patented technology, which is a CE-certified class IIa medical device for detecting atrial fibrillation.
In 2017, Mikko joined the University of Turku as a University Lecturer. Their research interests primarily revolve around biomedical applications, cardiovascular diseases, sensor technology, floating-gate technology, and neuromorphic engineering.
Prior to these roles, Mikko worked at BMH Wood Technology Oy as a Training & Documentation Engineer from 2000 to 2001.
Mikko Pänkäälä obtained a Doctor of Philosophy (PhD) degree in Electrical and Electronics Engineering from the University of Turku, with their education ending in 2001. Prior to that, they pursued a B.Sc. degree in Automotive and Transportation Engineering from the Turku University of Applied Sciences between 1995 and 1999. Mikko also holds a Lic.Sc. degree in Microelectronics from the University of Turku, although the specific years of completion are not provided.
This person is not in any offices
CardioSignal
CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics. CardioSignal's patented technology enables a digital cardiac biomarker for several major heart diseases, representing a breakthrough in the fight against heart disease, the world's most expensive and lethal disease.CardioSignal's digital cardiac biomarkers can replace invasive and expensive standard care technologies, allowing for faster and less expensive care.